Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease
Open Access
- 1 May 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (9), E222-E225
- https://doi.org/10.1002/ajh.25843
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and QuantificationJournal of Proteome Research, 2020
- Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trialBlood, 2019
- Platelet Protein Glycosylation in Immune ThrombocytopeniaBlood, 2018
- MASS‐FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptomsAmerican Journal of Hematology, 2018
- A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interferenceBlood, 2018
- Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsLeukemia, 2018
- The utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinicAmerican Journal of Hematology, 2017
- Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryClinical Chemistry, 2016
- Cold agglutinin diseaseBlood, 2013